DUBLIN--(BUSINESS WIRE)--Sep 7, 2018--The "Global Antithrombin Market - by Source, Dosage Form, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Antithrombin Market was worth 471.5 Million USD in 2017 and it is estimated to grow to 639.11 Million USD by 2023 with a CAGR of 5.2% between 2017 and 2023.Antithrombin is a blood protein, which naturally functions as a mild blood thinner. Antithrombin helps to control too much clotting of blood. A person with low antithrombin levels has more tendencies to clot more easily and vice-versa.

Europe is expected to hold the largest share of Global Antithrombin Market due to significant adoption of antithrombin therapies followed by North America. Asia Pacific is expected to have the leading growth rate of 6.32%.

Drivers Vs. Constraints

Rising prevalence of hereditary antithrombin deficiency and rising antithrombin treatment among adults are the reasons which drive the Global Antithrombin Market growth.

Industry Structure and Updates

The key companies as Grifols, Shire Plc., and rEVO Biologics Inc. are engaged in research and development in order to accentuate their respective market shares.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Antithrombin Market Segmentation, Forecasts and Trends - by Source

5.1. Human

5.2. Goat Milk

5.3. Others

6. Global Antithrombin Market Segmentation, Forecasts and Trends - by Dosage Form

6.1. Liquid

6.2. Lyophilized

7. Global Antithrombin Market Segmentation, Forecasts and Trends - by Application

7.1. Diagnostics

7.2. Therapeutics

7.3. Research

8. Global Antithrombin Market Segmentation, Forecasts and Trends - by Region

9. Company Market Share Analysis

10. Company Profiles

GrifolsrEVO Biologics, Inc.Scripps Laboratories, Inc.Diapharma Group, Inc.Lee Bisolutions, IncDem ilac, IncOctapharma AGKedrion S.p.A.CSL LimitedShire plcFor more information about this report visit https://www.researchandmarkets.com/research/w27cp4/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180907005224/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Coagulation and Hemostasis Testing

KEYWORD:

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/07/2018 08:53 AM/DISC: 09/07/2018 08:53 AM

http://www.businesswire.com/news/home/20180907005224/en